Related Experiment Video
Updated: May 12, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Lung function impairment in children post-tuberculosis treatment: a systematic review and meta-analysis
Hanhan Wu1, Yazhen Lang1, Luqing Jin1
1Department of Tuberculosis, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
Background:
Pulmonary tuberculosis (PTB) in childhood can result in persistent lung function impairment in adults, but data among children remain limited. This systematic review and meta-analysis aimed to summarize and update current evidence on pulmonary function outcomes after PTB treatment in children.
Methods:
We searched PubMed, Embase, Web of Science, and Scopus up to October 23, 2025. Eligible studies included children (≤18 years) with PTB who underwent post-treatment spirometry. Pooled mean z-scores for FEV₁, FVC, and FEV1/FVC ratio were calculated using random-effects models. For comparative studies, standardised mean differences (Hedges' g) were derived to compare post-PTB children with healthy controls.
Results:
Nine studies were included. The pooled post-treatment mean z-scores indicated significant reductions in both FEV₁ (-1.51, 95% CI -2.38 to -0.64) and FVC (-1.36, 95% CI -2.60 to -0.12), while the FEV1/FVC ratio showed no significant deviation (0.04, 95% CI -1.29 to 1.37). In case-control comparisons, post-PTB children had significantly lower FEV₁ (Hedges' g = -0.46, 95% CI -0.78 to -0.13) and FVC (Hedges' g = -0.29, 95% CI -0.50 to -0.08) compared with controls, while the FEV1/FVC ratio (Hedges' g = -0.32, 95% CI -0.58 to -0.06) showed only a marginal decline. Heterogeneity across analyses was moderate to high (I2 = 55%-98%).
Conclusions:
This updated systematic review and meta-analysis indicates that children who have completed PTB treatment frequently exhibit FEV₁ and FVC values below age matched reference levels, although estimates vary substantially across studies. Pooled effect sizes should be interpreted as indicative of association rather than precise estimates of magnitude. Additional prospective, microbiologically confirmed, and age-specific studies are necessary to better understand the long-term effects of childhood TB on lung development.
Systematic Review Registration:
https://www.crd.york.ac.uk/prospero/, PROSPERO CRD420251166413.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders